Gamma delta T cell culture medium, culture method and application

By adding cytokines, bisphosphate and berberine to the γδT cell culture medium and combining with autologous plasma, the problem of low amplification rate of γδT cell culture in the existing technology has been solved, and efficient cell proliferation and purity improvement has been achieved. Clinical application of γδT cells.

CN118909937APending Publication Date: 2024-11-08深圳泽医细胞治疗集团有限公司

Patent Information

Application Number
CN202411161220.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing γδ T cell culture method has a low amplification rate, and it is difficult to cultivate high-purity active γδ T cells in vitro.

Method used

Using γδT cell culture medium including AIM-V culture medium, cytokines, bisphosphate and berberine, by adding 100-1000U/mL IL-2, 10-50ng/mL IL-7, 10- 50 ng/mL IL-15, 10-20 ng/mL IL-18, 10-20 ng/mL IL-21 and 0.25-5 μM berberine combine with 5-10% autologous plasma to promote the proliferation and amplification of γδT cells.

Benefits of technology

It significantly improves the amplification and survival rate of γδT cells, enhances the function of cells, improves cell purity and expansion folds, and can make the proportion of γδT cells reach more than 60%, close to 80% within 14 days.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909937A_ABST
    Figure CN118909937A_ABST
Patent Text Reader

Abstract

The invention provides a gamma delta T cell culture medium, a culture method and application, the gamma delta T cell culture medium comprises a basal culture medium, cell factors, bisphosphonate and berberine, and the concentration of the berberine is 0.25-5 mu M. According to the delta T cell culture medium, berberine is combined with other components, proliferation of gamma delta T cells is promoted, the survival rate of the gamma delta T cells can be increased, and the amplification rate of the gamma delta T cells can be obviously increased.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of γδT cell culture, and in particular to a γδT cell culture medium, a culture method and an application thereof. Background Art

[0002] γδT cells are a type of non-classical T cells in the immune system. They are mainly distributed in the mucosa and subcutaneous tissues such as the intestine, respiratory tract, and urogenital tract. They are one of the main components of intraepidermal lymphocytes and intraepithelial lymphocytes (IEL) in mucosal tissues. In healthy adults, γδT cells account for 1% to 5% of peripheral blood T cells. However, γδT cells can directly kill cancer cells and tumor stem cells, recognize carcinoembryonic antigens, and directly kill tumor cells through the perforin granzyme pathway. In addition, γδT cells also play an important role in controlling viral infections and regulating autoimmune diseases.

[0003] Given the significant therapeutic effects of γδT cell therapy in cancer and viral diseases, being able to culture high-purity and active γδT cells in vitro is an urgent problem to be solved. However, the existing γδT cell culture methods have a low proliferation rate. How to improve the proliferation rate of γδT cells is an urgent problem to be solved. Summary of the invention

[0004] The present invention provides a γδT cell culture medium, a culture method and an application thereof. The main purpose of the present invention is to solve the problem of low culture expansion rate of γδT cells in existing culture technologies.

[0005] Content of the present invention is as follows:

[0006] The first aspect of the present invention provides a γδT cell culture medium, comprising: a basal culture medium, cytokines, bisphosphonates and berberine, wherein the concentration of the berberine is 0.25 to 5 μM.

[0007] In the γδT cell culture medium of the present invention, the basal culture medium includes one of AIM-V culture medium, KBM-581 culture medium and RPMI-1640. The basal culture medium provides basic substances for cell nutrition and cell proliferation, and is also a living environment for cell growth and reproduction. In the present invention, the selected basal culture medium is AIM-V culture medium.

[0008] Wherein, bisphosphonates, cytokines and berberine are also added to the culture medium, and the components work together in the culture medium to increase the proliferation rate of γδT cells.

[0009] Berberine, also known as berberine, is a quaternary ammonium alkaloid isolated from the Chinese herbal medicine Coptis chinensis and is the main active ingredient of Coptis chinensis for antibacterial effect. Due to its antibacterial effect, berberine can be used as an antibacterial component for cell culture in some occasions, so it can increase the survival rate of certain cells. The inventors of the present invention have found that using berberine as a component of the γδT cell culture medium of the present invention has a promoting effect on the proliferation of γδT cells, not only improving their survival rate, but also significantly improving the expansion multiples of γδT cells.

[0010] In an optional embodiment of the first aspect of the present invention, the γδT cell culture medium further comprises 5-10% autologous plasma.

[0011] The addition of autologous plasma can meet the nutrient requirements of cell culture and help cells grow and proliferate in the culture environment.

[0012] Among them, autologous plasma can be used only in the early stage of culture, and no additional autologous plasma is required in the later stage of culture.

[0013] In an optional embodiment of the first aspect of the present invention, the cytokines include 100-1000 U / mL IL-2, 10-50 ng / mL IL-7, 10-50 ng / mL IL-15, 10-50 ng / mL IL-18, and 10-20 ng / mL IL-21.

[0014] The cytokine combination can stimulate the proliferation of γδT cells, improve the culture environment of γδT cells, improve culture efficiency and enhance cell quality, and can enhance the various functions of γδT cells, including anti-tumor, anti-infection, and immune regulation.

[0015] In an optional embodiment of the first aspect of the present invention, the bisphosphonate is one or both of pamidronate disodium and zoledronic acid.

[0016] In the present invention, the bisphosphonates are the cell proliferation promoting additives, and the bisphosphonates are pamidronate and / or zoledronic acid, which have a significant stimulating and amplifying effect in PBMC cultured γδT cells. By amplifying γδT cells, pamidronate and / or zoledronic acid help to enhance the body's immune response ability, thereby playing an important role in treating diseases such as tumors and infections. The concentration of the bisphosphonate is 1 to 10 μg / mL.

[0017] In an optional embodiment, the bisphosphonate is 5 μg / mL zoledronic acid. In other embodiments, the bisphosphonate may be 5 μg / mL pamidronate disodium.

[0018] As a second aspect of the present invention, the γδT cell culture medium of the present invention comprises: a basal culture medium, cytokines, bisphosphonates, berberine and autologous plasma, wherein the concentration of the berberine is 0.25-5 μM; the cytokines include 100-1000 U / mL IL-2, 10-50 ng / mL IL-7, 10-50 ng / mL IL-15, 10-50 ng / mL IL-18, and 10-20 ng / mL IL-21; the bisphosphonate is one of 1-10 μg / mL pamidronate disodium and 1-10 μg / mL zoledronic acid; and the amount of the autologous plasma added is 5-10%.

[0019] As a third aspect of the present invention, the present invention also provides a method for culturing γδT cells, comprising:

[0020] Obtaining cells to be processed;

[0021] According to a preset culture time, based on the γδT cell culture medium provided by the first invention of the present invention, culturing the cells to be treated;

[0022] The cultured cells were collected.

[0023] Specifically, in the γδT cell culture method of the present invention, the cells to be treated are PBMCs. The separated PBMCs are inoculated in a culture container and the γδT cell culture medium is added for culture, wherein the PBMC inoculation density is 3 to 8×10 6 Pieces / mL.

[0024] Furthermore, during the culture process, culture medium was added according to the culture conditions to maintain the cell concentration at 2.0 to 3.5×10 6 Pieces / mL.

[0025] Furthermore, the γδT cell culture period is 14 days. Autologous plasma is added 9 days before the culture. The concentration of the added autologous plasma is preferably 5-10%, preferably 10%. After 9 days, no additional autologous plasma is added. After the culture is completed, the cells are collected and the purity of the γδT cells, the expansion multiple, etc. are tested.

[0026] The culture container referred to in the present invention includes a culture bottle or a culture bag, such as a T25 or T75 culture bottle, a T175 culture bottle, a T225 culture bottle and a 1L culture bag, etc., which can be transferred or replaced according to the actual volume of the culture medium to ensure that there is enough space for culture.

[0027] In a fourth aspect of the present invention, a kit is provided, the kit comprising the γδT cell culture medium provided by the first invention of the present invention, the kit being used for culturing γδT cells and / or preparing exosomes.

[0028] Beneficial effects: The present invention provides a γδT cell culture medium, a culture method and an application, wherein the cell culture medium comprises a basal culture medium, cytokines, bisphosphonates and berberine, wherein the concentration of the berberine is 0.25 to 5 μM. The culture medium combines berberine with other components to promote the proliferation of γδT cells, and can not only improve the survival rate of γδT cells, but also significantly improve the expansion rate of γδT cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 Schematic diagram of the effect of different concentrations of berberine on the survival rate of total PBMC;

[0030] Figure 2 Schematic diagram of the effect of different concentrations of berberine on the proliferation of various immune cells in PBMC;

[0031] Figure 3 Schematic diagram of the expansion multiples of γδT cells in the examples and comparative examples;

[0032] Figure 4 Schematic diagram of flow cytometry detection of γδT cell purity in the examples and comparative examples. DETAILED DESCRIPTION

[0033] In order to make the purpose, technical solution and effect of the present invention clearer and more specific, the present invention is further described in detail below. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0034] As a first aspect of the present invention, the γδT cell culture medium of the present invention consists of component A, component B, component C and component D:

[0035] Component A is a basal culture medium, including one of AIM-V culture medium, KBM-581 culture medium, and RPMI-1640;

[0036] Component B is a bisphosphonate, including one of 1-10 μg / mL pamidronate disodium and 1-10 μg / mL zoledronic acid;

[0037] Component C is cytokines, 100-1000 U / mL IL-2, 10-50 ng / mL IL-7, 10-50 ng / mL IL-15, 10-50 ng / mL IL-18, 10-20 ng / mL IL-21; wherein the concentrations referred to are the number of active units of IL-2 contained in each milliliter of culture medium;

[0038] Component D is berberine, and the added concentration of berberine is 0.25-5 μM.

[0039] The γδT cell culture medium may further include autologous plasma, which is added during the first 0-9 days of culture in an amount of 5-10%, preferably 10%. The amount specifically refers to the amount of autologous plasma added to the cell culture medium being 5% to 10% of the total volume of the culture medium.

[0040] The kit of the present invention adds berberine to the culture medium, and is combined with cytokines and bisphosphonates to promote the survival rate and proliferation rate of γδT cells.

[0041] The present invention also claims protection for a preparation method based on a γδT cell culture medium, wherein the γδT cells obtained based on the preparation method account for more than 60% and can be as high as 79%.

[0042] The present invention also requests the application of γδT cell culture medium, which can be specifically applied to a kit, and the application of the protection kit in γδT cell expansion and γδT cell exosome preparation. The corresponding kit can increase the expansion rate of immune cells in vitro, and the cost of the immune cell culture kit is relatively low, which is convenient for enterprises to save costs.

[0043] In order to better illustrate the technical effect of the technical solution of the present invention, the present invention constructed the following embodiments and comparative examples for testing.

[0044] Example 1: The γδT cell culture medium of Example 1 comprises:

[0045] The basal medium was AIM-V medium;

[0046] Complete medium included 5 μg / mL zoledronic acid;

[0047] Complete medium included cytokines, 700 U / mL IL-2, 20 ng / mL IL-7, 150 ng / mL IL-15, 50 ng / mL IL-18, 10 ng / mL IL-21;

[0048] Complete medium included 0.25 μM berberine;

[0049] Complete culture medium included 10% autologous plasma.

[0050] The γδT cell culture steps are as follows:

[0051] S1: Isolation of human peripheral blood mononuclear cells (PBMC);

[0052] Wherein, the separation method in step S1 is Ficoll density gradient centrifugation;

[0053] S2: PBMCs were inoculated into culture vessels at a density of 3 to 8 × 10 6 / mL, and add the above complete medium for culture;

[0054] S3: During the culture process, add an appropriate amount of complete culture medium for cultivation. During the culture period, replenish the mixed culture medium immediately according to the cell density and culture medium color. The cell concentration should be maintained at 2.0-3.5×10 6 The cells were transferred to a suitable culture container according to the volume of culture medium, and autologous plasma was added only in the first 9 days of culture, and no more was added after 9 days until the 14th day of culture.

[0055] S4: After the culture is completed, the cells are collected and tested.

[0056] Example 2: The γδT cell culture medium of Example 2 comprises:

[0057] The basal medium was AIM-V medium;

[0058] Complete medium included 5 μg / mL zoledronic acid;

[0059] Complete medium included cytokines, 700 U / mL IL-2, 20 ng / mL IL-7, 150 ng / mL IL-15, 50 ng / mL IL-18, 10 ng / mL IL-21;

[0060] Complete medium included 2.5 μM berberine;

[0061] Complete culture medium included 10% autologous plasma.

[0062] Among them, the cultivation method of Example 2 is the same as that of Example 1.

[0063] Example 3: The γδT cell culture medium of Example 3 comprises:

[0064] The basal medium was AIM-V medium;

[0065] Complete medium included 5 μg / mL zoledronic acid;

[0066] Complete medium included cytokines, 700 U / mL IL-2, 20 ng / mL IL-7, 150 ng / mL IL-15, 50 ng / mL IL-18, 10 ng / mL IL-21;

[0067] Complete medium included 5 μM berberine;

[0068] Complete culture medium included 10% autologous plasma.

[0069] Among them, the cultivation method of Example 3 is the same as that of Example 1.

[0070] Comparative Example 1: The culture medium of Comparative Example 1 comprises:

[0071] The basal medium was AIM-V medium;

[0072] Complete medium included cytokines, 700 U / mL IL-2, 20 ng / mL IL-7, 150 ng / mL IL-15, 50 ng / mL IL-18, 10 ng / mL IL-21;

[0073] Complete culture medium included 10% autologous plasma.

[0074] Among them, the cultivation method of comparative example 1 is the same as that of embodiment 1.

[0075] Comparative Example 2: The culture medium of Comparative Example 2 comprises:

[0076] The basal medium was AIM-V medium;

[0077] Complete medium included 5 μg / mL zoledronic acid;

[0078] Complete medium included cytokines, 700 U / mL IL-2, 20 ng / mL IL-7, 150 ng / mL IL-15, 50 ng / mL IL-18, 10 ng / mL IL-21;

[0079] Complete culture medium included 10% autologous plasma.

[0080] Among them, the cultivation method of comparative example 2 is the same as that of embodiment 1.

[0081] Controlled test experiment

[0082] Test 1: Using the controlled variable method to test the effect of different concentrations of berberine on the survival rate of total PBMC

[0083] Test method: The concentrations of berberine were set to 0, 0.2, 0.4, 0.8, 1, 2.5, 5, and 10 μM, and the complete culture medium was AIM-V culture medium containing 10% FBS. PBMCs were cultured with each culture medium until the third day, and then the total cell survival rate was detected using the CCK8 kit. The test results are shown in the figure Figure 1 shown.

[0084] Figure 1 The figure is a schematic diagram of the effect of different concentrations of berberine on the survival rate of PBMC. It can be seen from the figure that berberine can improve the survival rate of PBMC. As the concentration of berberine increases, the improvement of the survival rate increases. When the concentration of berberine reaches 10 μM, the effect of increasing the survival rate of γδT cells is not obvious, and the cost rises relatively high. Therefore, the concentration of berberine is preferably 0.25-5 μM, and more preferably 2.5-5 μM.

[0085] Test 2: Effects of different concentrations of berberine on the proliferation of various immune cells in PBMC

[0086] Test method: The concentrations of berberine were set to 0, 0.25, and 5 μM, respectively, and the complete culture medium was AIM-V culture medium containing 10% FBS. PBMCs were cultured with each culture medium until day 14, and then flow cytometry was used to detect the proportion of various immune cells in the total cells. The results are as follows: Figure 2 shown.

[0087] from Figure 2 It can be seen that berberine has a significant effect on promoting the proliferation of double-negative T cells and γδT cells. For γδT cells, when there is no berberine, the proportion of γδT cells is only 37.2%, while when the concentration of berberine is 0.25μM, the proportion of γδT cells reaches 41.3%, and when the concentration of berberine is 5μM, the proportion of γδT cells can reach 50.7%.

[0088] Test 3: Cell viability assay

[0089] The cells collected in Example 1-3 and Comparative Example 1-2 at different culture times were stained with AO / PI, and the cells were counted using a cell counter to calculate the cell survival rate and cell number, and a cell expansion multiple diagram was drawn. The results are shown in FIG. Figure 3 shown.

[0090] from Figure 3 It can be seen that the embodiments of the present invention can increase the cell expansion multiple of γδT cells and have an expansion effect on the culture of γδT cells.

[0091] Test 4: γδT cell purity detection

[0092] The purity of γδT cells was tested on the total collected cells. The purity of γδT cells in the collected cells was tested by flow cytometry, and the antibodies used were: PerCP-Cy5.5-CD3 antibody, FITC anti-human TCRγ / δ antibody. γδT cells are CD3+TCRγ / δ+ cell population. The results are shown in Table 1 and Figure 4 shown.

[0093] Table 1. Proportion of γδT cells in each group (%)

[0094] Group Day 0 Day 14 Comparative Example 1 14.4±0.06 37.63±0.93 Comparative Example 2 14.4±0.06 52.47±0.23 Experimental Example 1 14.4±0.06 62.30±0.61 Experimental Example 2 14.4±0.06 73.80±0.17 Experimental Example 3 14.4±0.06 79.37±0.12

[0095] From Table 1 and Figure 4It can be seen that the culture medium of the embodiment of the present invention has a promoting effect on the proliferation of γδT cells. The addition of berberine within the range defined by the present invention can make the proportion of γδT cells reach more than 60%, and when the added concentration of berberine is 2.5μM-5μM, the proportion of γδT cells can reach more than 70% after 14 days of culture. When the added concentration is 5μM, the proportion of γδT cells after 14 days of culture is close to 80%. Therefore, the γδT cell culture medium of the present invention has a promoting effect on the proliferation of γδT cell culture, and provides strong support for the subsequent clinical use of γδT cells.

[0096] The present invention also provides a kit, which includes the γδT cell culture medium as described above, and the kit can be used in aspects such as γδT cell culture and supernatant exosome preparation.

[0097] As described above, the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features thereof may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A γδT cell culture medium, characterized in that include: Basic culture medium, cytokines, bisphosphonates and berberine, wherein the concentration of berberine is 0.25-5 μM.

2. The γδT cell culture medium according to claim 1, characterized in that The γδT cell culture medium also includes 5-10% autologous plasma.

3. The γδT cell culture medium according to claim 1, characterized in that The cytokines include 100-1000 U / mL IL-2, 10-50 ng / mL IL-7, 10-50 ng / mL IL-15, 10-50 ng / mL IL-18, and 10-20 ng / mL IL-21.

4. The γδT cell culture medium according to claim 1, characterized in that The bisphosphonate is one or both of pamidronate disodium and zoledronic acid, and the concentration of the bisphosphonate is 1-10 μg / mL.

5. The γδT cell culture medium according to claim 4, characterized in that The bisphosphonate was 5 μg / mL zoledronic acid.

6. The γδT cell culture medium according to claim 1, characterized in that The basic culture medium includes one of AIM-V culture medium, KBM-581 culture medium and RPMI-1640.

7. A γδT cell culture medium, characterized in that include: The invention relates to a basal culture medium, cytokines, bisphosphonates, berberine and autologous plasma, wherein the concentration of berberine is 0.25 to 5 μM; the cytokines include 100 to 1000 U / mL IL-2, 10 to 50 ng / mL IL-7, 10 to 50 ng / mL IL-15, 10 to 50 ng / mL IL-18 and 10 to 20 ng / mL IL-21; the bisphosphonate is one of 1 to 10 μg / mL pamidronate disodium and 1 to 10 μg / mL zoledronic acid; and the amount of autologous plasma added is 5 to 10%.

8. A method for culturing γδT cells, characterized in that: include: Obtaining cells to be processed; Cultivating the cells to be treated according to a preset culture time based on the γδT cell culture medium according to any one of claims 1 to 6; The cultured cells were collected.

9. The method for culturing γδT cells according to claim 8, characterized in that: The cells to be treated are PBMCs, and the culture period is 14 days.

10. A kit, characterized in that: The kit comprises the culture medium according to any one of claims 1 to 6, and the kit is used for culturing γδT cells and / or preparing exosomes.

Citation Information

Patent Citations

  • Berberine-containing serum-free medium for mesenchymal stem cells

    CN105112366A

  • Ex-vivo expansion culture medium of umbilical cord blood hematopoietic stem cells and application thereof

    CN105112374A

  • Medium for gamma delta T cells amplified in vitro and method

    CN106399241A

  • Mesenchymal stem cell culture medium additive and application thereof

    CN112662620A

  • Induction culture medium, culture medium composition and culture method for culturing novel gamma delta T cells

    CN114736857A

Cited By

  • Γδt cell culture medium, culture method and use

    WO2026040784A1